Abstract
Obesity and insulin resistance are major risk factors for a number of metabolic disorders, such as type 2 diabetes mellitus1,2. Insulin has been suggested to function as one of the adiposity signals to the brain for modulation of energy balance. Administration of insulin into the brain reduces food intake and body weight3,4,5, and mice with a genetic deletion of neuronal insulin receptors are hyperphagic and obese6. However, insulin is also an anabolic factor; when administered systemically, pharmacological levels of insulin are associated with body weight gain in patients7. In this study, we investigated the efficacy and feasibility of small molecule insulin mimetic compounds8,9 to regulate key parameters of energy homeostasis. Central intracerebroventricular (i.c.v.) administration of an insulin mimetic resulted in a dose-dependent reduction of food intake and body weight in rats, and altered the expression of hypothalamic genes known to regulate food intake and body weight. Oral administration of a mimetic in a mouse model of high-fat diet-induced obesity reduced body weight gain, adiposity and insulin resistance. Thus, insulin mimetics have a unique advantage over insulin in the control of body weight and hold potential as a novel anti-obesity treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Taylor, S.I. Deconstructing type 2 diabetes. Cell 97, 9–12 (1999).
Kopelman, P.G. Obesity as a medical problem. Nature 404, 635–643 (2000).
Woods, S.C., Lotter, E.C., McKay, L.D. & Porte, D. Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282, 503–505 (1979).
Schwartz, M.W., Figlewicz, D.P., Baskin, D.G., Woods, S.C. & Porte, D. Jr. Insulin in the brain: a hormonal regulator of energy balance. Endocr. Rev. 13, 387–414 (1992).
Woods, S.C., Schwartz, M.W., Baskin, D.G. & Seeley, R.J. Food intake and the regulation of body weight. Ann. Rev. Psychol. 51, 255–277 (2000).
Bruning, J.C. et al. Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122–2125 (2000).
DeFronzo, R. Pharmacological therapy for type 2 diabetes. Ann. Intern. Med .17, 281–303 (1999).
Zhang, B. et al. Discovery of a small molecule insulin mimetic with antidiabetic activity in mice. Science 284, 974–977 (1999).
Qureshi, S.A. et al. Activation of insulin signal transduction pathway and anti-diabetic activity of small molecule insulin receptor activators. J. Biol. Chem. 275, 36590–36595 (2000).
Sipols, A.J., Baskin, D.G. & Schwartz, M.W. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 44, 147–151 (1995).
Bernstein, I.L., Goehler, L.E. & Bouton, M.E. Relative potency of foods and drinks as targets in aversion conditioning. Behav. Neural. Biol. 37, 134–148 (1983).
Mitchell, D. et al. Poison induced pica in rats. Physiol. Behav. 17, 691–697 (1976).
Madden, L.J., Seeley, R.J. & Woods, S.C. Intraventricular neuropeptide Y decreases need-induced sodium appetite and increases pica in rats. Behav. Neurosci. 113, 826–832 (1999).
Stricker, E.M. & Verbalis, J.G. Central inhibitory control of sodium appetite in rats: correlation with pituitary oxytocin secretion. Behav. Neurosci. 101, 560–567 (1987).
Liu, K. et al. Discovery of a potent, highly selective, and orally efficacious small-molecule activator of the insulin receptor. J. Med. Chem. 43, 3487–3494 (2000).
Lowell, B.B. et al. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366, 740–742 (1993).
Spiegelman, B.M. & Flier, J.S. Adipogenesis and obesity: rounding out the big picture. Cell 87, 377–389 (1996).
Kahn, B.B. & Flier, J.S. Obesity and insulin resistance. J. Clin. Invest. 106, 473–481 (2000).
Considine, R.V. et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292–295 (1996).
Elchebly, M. et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283, 1544–1548 (1999).
Klaman, L.D. et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol. 20, 5479–5489 (2000).
Baura, G.D. et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J. Clin. Invest. 92, 1824–1830 (1991).
Acknowledgements
We thank D. Szalkowski and Z. Li for help with necropsy and J. Ronan for help with preparation of histology slides. This work was supported in part by grants from the DFG (M.Z.S.), the American Diabetes Association (Physician Scientist Training Award to E.L.A.) and NIH (S.C.W.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
G.M. Salituro, X.-M. Guan, K. Liu & B.B. Zhang are employees and shareholders of Merck and Co.
Rights and permissions
About this article
Cite this article
Air, E., Strowski, M., Benoit, S. et al. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity. Nat Med 8, 179–183 (2002). https://doi.org/10.1038/nm0202-179
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0202-179
This article is cited by
-
Inulin-enriched Megamonas funiformis ameliorates metabolic dysfunction-associated fatty liver disease by producing propionic acid
npj Biofilms and Microbiomes (2023)
-
A stepwise activation model for the insulin receptor
Experimental & Molecular Medicine (2023)
-
Hydroxyoleoside-type seco-iridoids from Symplocos cochinchinensis and their insulin mimetic activity
Scientific Reports (2019)
-
Chronic Metabolic Derangement-Induced Cognitive Deficits and Neurotoxicity Are Associated with REST Inactivation
Molecular Neurobiology (2019)
-
Physiological adaptations to weight loss and factors favouring weight regain
International Journal of Obesity (2015)